China Resources Double-Crane Pharmaceutical Co.,Ltd. (SHA:600062)
China · Delayed Price · Currency is CNY 19.25
+0.12 (0.63%)
Oct 31, 2025, 2:44 PM CST
SHA:600062 Market Cap
SHA:600062 has a market cap or net worth of 19.89 billion as of October 31, 2025. Its market cap has decreased by -13.62% in one year.
Market Cap
19.89B
Enterprise Value
19.48B
Revenue
10.95B
Ranking
n/a
PE Ratio
12.58
Stock Price
19.25
Market Cap Chart
Since March 1, 2004, SHA:600062's market cap has increased from 9.40B to 19.89B, an increase of 111.48%. That is a compound annual growth rate of 3.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2025 | 19.75B | -2.81% |
| Dec 31, 2024 | 20.32B | 5.43% |
| Dec 29, 2023 | 19.28B | 5.47% |
| Dec 30, 2022 | 18.28B | 31.03% |
| Dec 31, 2021 | 13.95B | 11.51% |
| Dec 31, 2020 | 12.51B | -8.12% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 417.53B |
| WuXi AppTec | 288.80B |
| Shenzhen Mindray Bio-Medical Electronics | 260.07B |
| Sichuan Biokin Pharmaceutical | 138.93B |
| Shanghai United Imaging Healthcare | 115.65B |
| Aier Eye Hospital Group | 112.57B |
| Zhangzhou Pientzehuang Pharmaceutical., | 106.79B |
| Yunnan Baiyao Group Co.,Ltd | 100.78B |